Beyond KRAS: The quest for novel genetic markers predictive for response to anti-epidermal growth factor receptor (EGFR) therapy in patients with metastatic colorectal cancer (mCRC).

作者: A. Sood , D. McClain , R. Seetharam , M. Al-rahamneh , A. Kaubisch

DOI: 10.1200/JCO.2010.28.15_SUPPL.3567

关键词:

摘要: 3567 Background: EGFR directed therapy is limited by mutations in KRAS or BRAF; however, the search for other predictive biomarkers critical (Clin Cancer Res, 2008; 68: 1953). In our study, we e...

参考文章(0)